ESG

A court ruling dismisses a lawsuit against Montclair's Lackawanna Plaza plan, clearing the path for the long-stalled, transformative project to proceed.

The Chinese EV maker released landmark ESG and climate reports, boosting transparency as it navigates tough regulations and mixed investor sentiment.

A new partnership between a Chinese biotech and a Brazilian public institute aims to slash the $500k cost of CAR-T therapy, making it accessible to all.

An award-winning film and a new community partnership highlight the landscaping industry's powerful, quiet shift from gas to battery-powered equipment.

A Swedish firm pivots from solar rooftops to electrify trucking corridors, betting on AI and battery leasing to solve a multi-billion-euro problem.

With a massive $54M Series A, Vivatides Therapeutics aims to solve RNA's biggest delivery problem, unlocking new treatments for a host of chronic diseases.

A new facility in Estonia is breaking Europe's reliance on China for critical minerals essential for electric vehicles and wind turbines.

The tech leader will showcase an integrated platform turning supply chain complexity and regulatory hurdles like the Digital Product Passport into a competitive edge.

At analytica 2026, Haier Biomedical unveiled its 'In Europe, For Europe' strategy, challenging market leaders with integrated solutions and local roots.

Private equity giant Warburg Pincus is launching a dedicated fund, betting on Europe's rearmament and quest for strategic autonomy amid rising global tensions.

Tata Power partners with Databricks, leveraging AI to unify its operations, accelerate renewable energy integration, and redefine the future of power in India.

A new partnership combines local infrastructure with global expertise, aiming to streamline development for startups and solidify Singapore's biotech leadership.

A live demonstration shows patients can now securely access medical records via an app, a milestone in making U.S. healthcare truly interoperable.

The Rally Hotel is weaving sustainability and social impact into its core, but can its certified programs and local partnerships win over skeptical travelers?

Greenidge Generation's debt restructuring gives it breathing room but leaves bondholders in limbo after regulators deny a public market for the new notes.

Backed by FDA approval and strong clinical data, EBR Systems' leadless WiSE pacer is set to transform cardiac therapy for previously untreatable patients.

An investigation into a Florida 'trash school' reveals a national crisis of toxic dumps near schools, disproportionately harming children of color.

Blackstone invests in Rowan Digital Infrastructure, signaling a massive push to secure the power-hungry data centers essential for the AI revolution.

Five new clinical trials in Chicago repurpose existing drugs for PTSD, cancer, and more, offering a faster, cheaper path to treating unsolved diseases.

A decade after AlphaGo's triumph, a new Go AI faces pros on a single GPU to prove it can be meaningful and trustworthy in a complex human world.